[1]
|
Cordovil, K. (2018) Sickle Cell Disease: A Genetic Disorder of Beta-Globin. In: Thalassemia and Other Hemolytic Anemias, IntechOpen, Isam Al-Zwaini. https://doi.org/10.5772/intechopen.74778
|
[2]
|
Jensen, F.B. (2009) The Dual Roles of Red Blood Cells in Tissue Oxygen Delivery: Oxygen Carriers and Regulators of Local Blood Flow. Journal of Experimental Biology, 212, 3387-3393. https://doi.org/10.1242/jeb.023697
|
[3]
|
Roy, S. and Ganguly, S. (2013) Sickle Cell Anemia, an Autosomal Recessive Disorder: A Review. International Journal of Molecular Genetics, 3, 63-67. http://www.ripublication.com/ijmg.htm
|
[4]
|
Hassel, K.L. (2010) Population Estimates of Sickle Cell Disease in the U.S. American Journal of Preventive Medicine, 38, S512-S521. https://doi.org/10.1016/j.amepre.2009.12.022
|
[5]
|
Anatomy of the Liver. https://www.slideteam.net/catalog/product/gallery/id/35454/image/262076
|
[6]
|
Roche, S.P. and Kobos, R. (2004) Jaundice in the Adult Patient. American Family Physician, 69, 299-304.
|
[7]
|
Kuntz, E. (2008) Hepatology: Textbook and Atlas. Springer, Berlin, 38.
|
[8]
|
Singh, A. and Jialal, I. (2019) Unconjugated Hyperbilirubinemia. StatPearls Publishing, Treasure Island. https://www.ncbi.nlm.nih.gov/books/NBK549796
|
[9]
|
Fabris, L., Cadamuro, M. and Okolicsanyi, L. (2009) The Patient Presenting with Isolated Hyperbilirubinemia. Digestive and Liver Disease, 41, 375-381. https://doi.org/10.1016/j.dld.2008.11.006
|
[10]
|
Shah, R., Taborda, C. and Chawla, S. (2017) Acute and Chronic Hepatobiliary Manifestations of Sickle Cell Disease: A Review. World Journal of Gastrointestinal Pathophysiology, 8, 108-116. https://doi.org/10.4291/wjgp.v8.i3.108
|
[11]
|
Johnson, C.S., Omata, M. and Tong, M.J. (1985) Liver Involvement in Sickle Cell Disease. Medicine, 64, 349-356. https://doi.org/10.1097/00005792-198509000-00007
|
[12]
|
Sheehy, T.W. (1977) Sickle Cell Hepatopathy. Southern Medical Journal, 70, 533-538. https://doi.org/10.1097/00007611-197705000-00008
|
[13]
|
Banerjee, S., Owen, C. and Chopra, S. (2001) Sickle Cell Hepatopathy. Hepatology, 33, 1021-1028. https://doi.org/10.1053/jhep.2001.24114
|
[14]
|
Gardner, K., Suddle, A., Kane, P., et al. (2014) How We Treat Sickle Hepatopathy and Liver Transplantation in Adults. Blood, 123, 2302-2307. https://doi.org/10.1182/blood-2013-12-542076
|
[15]
|
Gillis, J.H., Satapathy, S.K., Parsa, L., Sylvestre, P.B. and Dbouk, N. (2015) Acute Sickle Hepatic Crisis after Liver Transplantation in a Patient with Hb SC Disease. Case Reports in Transplantation, 2015, Article ID: 761740. https://doi.org/10.1155/2015/761740
|
[16]
|
Jeng, M.R., Rieman, M.D., Naidu, P.E., Kaste, S.C., Jenkins, J.J., Serjeant, G. and Wang, W.C. (2003) Resolution of Chronic Hepatic Sequestration in a Patient with Homozygous Sickle Cell Disease Receiving Hydroxyurea. Journal of Pediatric Hematology/Oncology, 25, 257-260. https://doi.org/10.1097/00043426-200303000-00015
|
[17]
|
Guimarães, J.A. and Silva, L.C.D.S. (2017) Sickle Cell Intrahepatic Cholestasis Unresponsive to Exchange Blood Transfusion: A Case Report. Revista Brasileira de Hematologia e Hemoterapia, 39, 163-166. https://doi.org/10.1016/j.bjhh.2017.02.006
|
[18]
|
Ahn, H., Li, C.-S. and Wang, W. (2005) Sickle Cell Hepatopathy: Clinical Presentation, Treatment, and Outcome in Pediatric and Adult Patients. Pediatric Blood & Cancer, 45, 184-190. https://doi.org/10.1002/pbc.20317
|
[19]
|
Teixeira, A.L., Viana, M.B., Roquete, M.L. and Toppa, N.H. (2002) Sickle Cell Disease: A Clinical and Histopathologic Study of the Liver in Living Children. Journal of Pediatric Hematology/Oncology, 24, 125-129. https://doi.org/10.1097/00043426-200202000-00013
|
[20]
|
Porzsolt, F., Rocha, N.G., Toledo-Arruda, A.C., et al. (2016) Efficacy and Effectiveness Trials Have Different Goals, Use Different Tools, and Generate Different Messages. Pragmatic and Observational Research, 6, 47-54.
|
[21]
|
Papafragkakis, H., Ona, M.A., Changela, K., et al. (2014) Acute Liver Function Decompensation in a Patient with Sickle Cell Disease Managed with Exchange Transfusion and Endoscopic Retrograde Cholangiography. Therapeutic Advances in Gastroenterology, 7, 217-223. https://doi.org/10.1177/1756283X14530781
|
[22]
|
Allali, S., de Montalembert, M., Brousse, V., et al. (2019) Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients. Journal of Clinical Medicine, 8, 1481. https://doi.org/10.3390/jcm8091481
|
[23]
|
Koullapis, N., Kouroupi, I.G. and Dourakis, S.P. (2005) Hepatobiliary Manifestations of Sickle Cell Disease. Haema, 8, 393-404.
|
[24]
|
Edwards, C.Q. (2002) Anemia and the Liver. Hepatobiliary Manifestations of Anemia. Clinical Liver Disease, 6, 891-907. https://doi.org/10.1016/S1089-3261(02)00050-8
|
[25]
|
Bauer, T.W., Moore, G.W. and Hutchins, G.M. (1980) The Liver in Sickle Cell Disease. A Clinicopathologic Study of 70 Patients. The American Journal of Medicine, 69, 833-837. https://doi.org/10.1016/S0002-9343(80)80008-8
|
[26]
|
Johnson, C.S., Omata, M., Tong, M.J., Simmons Jr., J.F., Weiner, J. and Tatter, D. (1985) Liver Involvement in Sickle Cell Disease. Medicine (Baltimore), 64, 349-356. http://doi.org/10.1097/00005792-198509000-00007
|
[27]
|
Giannini, E.G., Testa, R. and Savarino, V. (2005) Liver Enzyme Alteration: A Guide for Clinicians. CMAJ, 172, 367-379. https://doi.org/10.1503/cmaj.1040752
|
[28]
|
Aydinli, M. and Bayraktar, Y. (2007) Budd-Chiari Syndrome: Etiology, Pathogenesis and Diagnosis. World Journal of Gastroenterology, 13, 2693-2696. https://doi.org/10.3748/wjg.v13.i19.2693
|
[29]
|
Arnold, K.E., Char, G. and Serjeant, G.R. (1993) Portal Vein Thrombosis in a Child with Homozygous Sickle-Cell Disease. West Indian Medical Journal, 42, 27-28.
|
[30]
|
Zhou, H., et al. (2000) Multiple Macroregenerative Nodules in Liver Cirrhosis Due to Budd-Chiari Syndrome. Case Reports and Review of the Literature. Hepatogastroenterology, 47, 522-527.
|
[31]
|
Bond, L.R., Hatty, S.R., Horn, M.E., Dick, M., Meire, H.B. and Bellingham, A.J. (1987) Gallstones in Sickle Cell Disease in the United Kingdom. British Medical Journal, 295, 234-236. https://doi.org/10.1136/bmj.295.6592.234
|
[32]
|
Kimiko Suzue Department of Pathology—Presentation Transcript. http://slideplayer.com/slide/9486797
|
[33]
|
Tanaja, J. and Meer, J.M. (2019) Cholelithiasis. StatPearls Publishing, Treasure Island.
|
[34]
|
Khan, Steven, J.T. and Dinko, N. (2009) Zinc Deficiency Causing Hyperammonemia and Encephalopathy in a Sickle Cell Patient. Chest, 136, 37S-7d. https://doi.org/10.1378/chest.136.4_MeetingAbstracts.37S-d
|
[35]
|
Nouraie, M., Nekhai, S. and Gordeuk, V.R. (2012) Sickle Cell Disease Is Associated with Decreased HIV But Higher HBV and HCV Comorbidities in US Hospital Discharge Records: A Cross-Sectional Study. Sexually Transmitted Infections, 88, 528-533. https://doi.org/10.1136/sextrans-2011-050459
|
[36]
|
Allain, J.P., Bianco, C., Blajchman, M.A., et al. (2005) Protecting the Blood Supply from Emerging Pathogens: The Role of Pathogen Inactivation. Transfusion Medicine Reviews, 19, 110-126. https://doi.org/10.1016/j.tmrv.2004.11.005
|
[37]
|
Al-Suliman, A.M., Busaobiuah, J., Al-Baqshi, M., Qadiaub, K., Mohammad, B., Homrany, H., Aljassam, A. and Khan, S.A. (2013) Prevalence of Hepatitis B and C in Adult Sickle Cell Disease Patients in the Eastern Province of Saudi Arabia. Journal of Applied Hematology, 4, 33-35.
|
[38]
|
Hassan, M., et al. (2003) HCV in Sickle Cell Disease. Journal of the National Medical Association, 95, 864-874.
|
[39]
|
Boettler, T., Newsome, P.N., Mondelli, M.U., Maticic, M., Cordero, E., Cornberg, M. and Berg, T. (2020) Care of Patients with Liver Disease during the COVID-19 Pandemic: EASL-ESCMID Position Paper. JHEP Reports. https://doi.org/10.1016/j.jhepr.2020.100113
|
[40]
|
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1101/2020.02.06.20020974
|
[41]
|
Schütte, A., Ciesek, S., Wedemeyer, H. and Lange, C.M. (2019) Influenza Virus Infection as Precipitating Event of Acute-on-Chronic Liver Failure. Journal of Hepatology, 70, 797-799. https://doi.org/10.1016/j.jhep.2018.11.015
|
[42]
|
Powell, L.W., Subramaniam, V.N. and Yapp, T.R. (2000) Haemochromatosis in the New Millennium. Journal of Hepatology, 32, 48-62. https://doi.org/10.1016/S0168-8278(00)80415-8
|
[43]
|
McDowell, L.A. and Sticco, K.L. (2020) Iron Overload. StatPearls Publishing, Treasure Island. https://www.ncbi.nlm.nih.gov/books/NBK526131
|
[44]
|
McLaren, G.D., McLaren, C.E., Adams, P.C., Barton, J.C., Reboussin, D.M., Gordeuk, V.R., Acton, R.T., Harris, E.L., Speechley, M.R., Sholinsky, P., Dawkins, F.W., Snively, B.M., Vogt, T.M. and Eckfeldt, J.H. (2008) Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators. Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening. Canadian Journal of Gastroenterology, 22, 923-930.
https://doi.org/10.1155/2008/907356
|
[45]
|
Darbari, D.S., Kple-Faget, P., Kwagyan, J., Rana, S., Gordeuk, V.R. and Castro, O. (2006) Circumstances of Death in Adult Sickle Cell Disease Patients. American Journal of Hematology, 81, 858-863. https://doi.org/10.1002/ajh.20685
|
[46]
|
Porter, J. and Garbowski, M. (2013) Consequences and Management of Iron Overload in Sickle Cell Disease. Hematology—American Society of Hematology Education Program, 2013, 447-456. https://doi.org/10.1182/asheducation-2013.1.447
|
[47]
|
Andrade, R.J. and Robles-Díaz, M. (2020) Diagnostic and Prognostic Assessment of Suspected Drug-Induced Liver Injury in Clinical Practice. Liver International, 40, 6-17. https://doi.org/10.1111/liv.14271
|
[48]
|
(2012) Hydroxyurea LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. https://www.ncbi.nlm.nih.gov/books/NBK548724
|
[49]
|
(2012) Deferasirox LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. https://www.ncbi.nlm.nih.gov/books/NBK548039
|
[50]
|
Hatami, B., Saffaei, A., Jamali, F. and Abbasinazari, M. (2020) Glutamine Powder-Induced Hepatotoxicity: It Is Time to Understand the Side Effects of Sports Nutritional Supplements. Gastroenterology and Hepatology from Bed to Bench, 13, 86-89.
|
[51]
|
deLemos, A.S., Ghabril, M., Rockey, D.C., et al. (2016) Amoxicillin-Clavulanate-Induced Liver Injury. Digestive Diseases and Sciences, 61, 2406-2416. https://doi.org/10.1007/s10620-016-4121-6
|
[52]
|
Andrade, R.J., Robles, M. and Lucena, M.I. (2009) Re-Challenge in Drug-Induced Liver Injury: The Attractive Hazard. Expert Opinion on Drug Safety, 8, 709-714. https://doi.org/10.1517/14740330903397378
|
[53]
|
MedlinePlus (2014) Drug-Induced Hepatitis: MedlinePlus Medical Encyclopedia.
|
[54]
|
Chalasani, N.P., Hayashi, P.H., Bonkovsky, H.L., et al. (2014) ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. American Journal of Gastroenterology, 109, 950-966. https://doi.org/10.1038/ajg.2014.131
|
[55]
|
Lerut, J.P., Clayes, N., Laterre, P.F., Lavenne-Pardonge, E., Ciccarelli, O., Cavallaro, S., Palazzo, U., Renda, D., Rigano, P. and Maggio, A. (1999) Hepatic Sickling: An Unusual Case of Liver Allograft Dysfunction. Transplantation, 67, 65-68. https://doi.org/10.1097/00007890-199901150-00010
|
[56]
|
Gee, Y., Geong, Kang, S., Lee, C. and Burgio, A. (2019) An Updated Review on the Epidemiology, Pathophysiology, Etiology, and Diagnosis of Liver Cirrhosis.
|
[57]
|
Cunha, J.P. and Marks, J.W. Cirrhosis (Liver). https://www.medicinenet.com/cirrhosis/article.htm#what_is_sofosbuvir_and_velpatasvir_what_is _sofosbuvir_and_velpatasvir_used_for
|
[58]
|
Daugaard, T.R., Pommergaard, H.-C., Rostved, A.A. and Rasmussen, A. (2018) Postoperative Complications as a Predictor for Survival after Liver Transplantation—Proposition of a Prognostic Score. International Hepato-Pancreato-Biliary, 20, 815-822. https://doi.org/10.1016/j.hpb.2018.03.001
|
[59]
|
Ozdogu, H., Boga, C., Yeral, M., et al. (2018) Allogenic Peripheral Stem Cell Transplantation from HLA-Matched Related Donors for Adult Sickle Cell Disease: Remarkable Outcomes from a Single-Center Trial. Bone Marrow Transplant, 53, 880-890. https://doi.org/10.1038/s41409-018-0111-y
|
[60]
|
Perri, R., Assi, M., Talwalkar, J., Heimbach, J., Hogan, W., Moore, S.B. and Rosen, C.B. (2007) Graft vs. Host Disease after Liver Transplantation: A New Approach Is Needed. Liver Transplantation, 13, 1092-1099. https://doi.org/10.1002/lt.21203
|
[61]
|
Langnas, A.N., Marujo, W., Stratta, R.J., Wood, R.P. and Shaw, B.W. (1991) Vascular Complications after Orthotopic Liver Transplantation. The American Journal of Surgery, 161, 76-83. https://doi.org/10.1016/0002-9610(91)90364-J
|
[62]
|
Ishigami, K., Zhang, Y., Rayhill, S., Katz, D. and Stolpen, A. (2004) Does Variant Hepatic Artery Anatomy in a Liver Transplant Recipient Increase the Risk of Hepatic Artery Complications after Transplantation? American Journal of Roentgenology, 183, 1577-1584. https://doi.org/10.2214/ajr.183.6.01831577
|
[63]
|
Christoforidis, E., Vasiliadis, K., Goulimaris, I., Tsalis, K., Kanellos, I., Papachilea, T., Tsorlini, E. and Betsis, D. (2007) A Single Center Experience in Minimally Invasive Treatment of Postcholecystectomy Bile Leak, Complicated with Biloma Formation. Journal of Surgical Research, 141, 171-175. https://doi.org/10.1016/j.jss.2006.07.012
|
[64]
|
Lee, J.H. and Suh, J.I. (2007) A Case of Infected Biloma Due to Spontaneous Intrahepatic Biliary Rupture. The Korean Journal of Internal Medicine, 22, 220-224. https://doi.org/10.3904/kjim.2007.22.3.220
|
[65]
|
Lebensburge, J., Esbenshade, A., Blakely, M., Hankins, J. and Wang, W. (2008) Biloma and Pneumobilia in Sickle Cell Disease. Brief Report. Pediatric Blood Cancer, 51, 153-316. https://doi.org/10.1002/pbc.21575
|
[66]
|
Miro, A.G., De Seta, C., Arenga, G., Russo, M. and Lombardi, D. (2002) Treatment of Major Iatrogenic Lesions of the Bile Ducts. Annali Italiani di Chirurgia, 73, 35-39.
|
[67]
|
Mohammad, M.K., Zhou, Z., Cave, M., Barve, A. and McClain, C.J. (2012) Zinc and Liver Disease. Nutrition in Clinical Practice, 27, 8-20. https://doi.org/10.1177/0884533611433534
|
[68]
|
Jagadeeswaran, R., et al. (2018) The Impact of Selenium Deficiency on a Sickle Cell Disease Mouse Model. Blood, 132, 3645. https://doi.org/10.1182/blood-2018-99-111833
|
[69]
|
Tayo, B.O., Akingbola, T.S., Salako, B.L., et al. (2014) Vitamin D Levels Are Low in Adult Patients with Sickle Cell Disease in Jamaica and West Africa. BMC Hematology, 14, Article No. 12. https://doi.org/10.1186/2052-1839-14-12
|
[70]
|
Saeed, A., Hoekstra, M., Hoeke, M.O., Heegsma, J. and Faber, K.N. (2017) The Interrelationship between Bile Acid and Vitamin A Homeostasis. BBA Molecular and Cell Biology of Lipids, 1862, 496-512. https://doi.org/10.1016/j.bbalip.2017.01.007
|
[71]
|
Kozeniecki, M., Ludke, R., Kerner, J. and Patterson, B. (2020) Micronutrients in Liver Disease: Roles, Risk Factors for Deficiency, and Recommendations for Supplementation. Nutrition in Clinical Practice, 35, 50-62. https://doi.org/10.1002/ncp.10451
|
[72]
|
Kamineni, P., Chirla, S., Dinh, K., Hasan, S., Nidhiry, E., Kwagyan, J., Naab, T., Lombardo, F., Castro, O. and Dawkins, F. (2006) Low Cobalamin Levels in African Americans with and without Sickle Cell Disease. Journal of the National Medical Association, 98, 352-356.
|
[73]
|
Ajayi, O.I., Bwayo-Weaver, S., Chirla, S., et al. (2013) Cobalamin Status in Sickle Cell Disease. International Journal of Laboratory Hematology, 35, 31-37. https://doi.org/10.1111/j.1751-553X.2012.01457.x
|
[74]
|
Czaja, A.J. (2004) Autoimmune Liver Disease. Current Opinion in Gastroenterology, 20, 231-240. https://doi.org/10.1097/00001574-200405000-00007
|
[75]
|
Autoimmune Hepatitis|Genetic and Rare Diseases Information Center (GARD)— An NCATS Program. Rarediseases.info.nih.gov.
|
[76]
|
Jitraruch, S., Fitzpatrick, E., Deheragoda, M., et al. (2017) Autoimmune Liver Disease in Children with Sickle Cell Disease. The Journal of Pediatrics, 189, 79-85.e2. https://doi.org/10.1016/j.jpeds.2017.06.035
|
[77]
|
Maher, M.M. and Mansour, A.H. (2009) Study of Chronic Hepatopathy in Patients with Sickle Cell Disease. Gastroenterology Research, 2, 338-343. https://doi.org/10.4021/gr2009.12.1327
|